Friday 4 October / 10.15-11.45

Symposium

AF & HF: recent advances in therapy

Chairs:
J. Brachmann / Coburg, Germany
A. Proclemer / Udine, Italy

• Prevalence and significance of AF in HF with reduced and preserved EF
  R Gopinathannair / Overland Park, USA
• Medical drug therapy: which role today?
  Capucci / Ancona, Italy
• After AATAC and CASTLE-AF, should AF catheter ablation be labeled as class I indication?
  M.G. Chelu / Salt Lake City, USA
• Biventricular/HB pace-and-ablate: when, who, and why?
  M. Grimaldi / Acquaviva delle Fonti, Italy